NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Oct. 21, 2015--
Lantheus
Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of
Lantheus Medical Imaging, Inc. (“LMI”), today announced that it will
host a conference call at 4:30 p.m. ET on Wednesday, November 4, 2015,
to discuss its financial and operating results for the third quarter of
2015.
To access the live conference call via telephone, please dial
1-866-498-8390 (U.S. callers) or 1-678-509-7599 (international callers)
and provide passcode 57541328. A live audio webcast of the call also
will be available on the homepage of the Company’s website at www.lantheus.com.
A replay of the telephone conference call and audio webcast will be
available from approximately 8:30 p.m. ET on November 4, 2015 through
midnight on November 18, 2015. To access a replay of the conference
call, dial 1-855-859-2056 (U.S. callers) or 1-404-537-3406
(international callers), and provide passcode 57541328.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus
Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc.
(“LMI”), which is a global leader in developing, manufacturing, selling
and distributing innovative diagnostic imaging agents and products. LMI
provides a broad portfolio of products, which are primarily used for the
diagnosis of cardiovascular diseases. LMI’s key products include the
echocardiography contrast agent DEFINITY® Vial for
(Perflutren Lipid Microsphere) Injectable Suspension; TechneLite®
(Technetium Tc99m Generator), a technetium-based generator that provides
the essential medical isotope used in nuclear medicine procedures; and
Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent
used to evaluate pulmonary function and for imaging the lungs. The
Company is headquartered in North Billerica, Massachusetts, and has
offices in Puerto Rico, Canada and Australia. For more information,
visit www.lantheus.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151021006684/en/
Source: Lantheus Holdings, Inc.
Lantheus Holdings, Inc.
Investor Relations
John
Bakewell, 978-436-7073
or
Media Relations
Meara
Murphy, 978-671-8508